Post-approval studies (Phase 4)Study completedNCT00411736What this trial is testingScandinavian Cystic Fibrosis Azithromycin StudyWho this might be right forCystic Fibrosis Rigshospitalet, Denmark 45
Large-scale testing (Phase 3)Study completedNCT00712166What this trial is testingSafety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. AeruginosaWho this might be right forCystic FibrosisLung InfectionPseudomonas Aeruginosa Gilead Sciences 160
Not applicableStudy completedNCT01651455What this trial is testingRetrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000Who this might be right forCystic Fibrosis Chiesi Farmaceutici S.p.A. 92
Not applicableWithdrawnNCT01090908What this trial is testingEvaluation of Ciprofloxacin for Inhalation to Cystic Fibrosis Patients With P. AeruginosaWho this might be right forCystic Fibrosis Aradigm Corporation
Large-scale testing (Phase 3)Study completedNCT02054156What this trial is testingOPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic FibrosisWho this might be right forCystic Fibrosis Bonnie Ramsey 221
Not applicableUnknownNCT04803695What this trial is testingRole of Pseudomonas Aeruginosa Biofilms in Exacerbations in Patients With Bronchiectasis With and Without Chronic Obstructive Pulmonary DiseaseWho this might be right forBronchiectasisMicrobial ColonizationPseudomonas Aeruginosa+1 more Hospital Clinic of Barcelona 96
Not applicableUnknownNCT05251584What this trial is testingEffects of Topical Gentamicin on the Prevention of Peritoneal Dialysis Related InfectionWho this might be right forPeritoneal Dialysis-related Infection Phramongkutklao College of Medicine and Hospital 60
Large-scale testing (Phase 3)Study completedNCT01069705What this trial is testingSecond Open Label Extension to Bridging Study CTBM100C2303Who this might be right forPulmonary InfectionsPseudomonas Aeruginosa Novartis Pharmaceuticals 49
Post-approval studies (Phase 4)Ended earlyNCT02248922What this trial is testingEvaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.AeruginosaWho this might be right forChronic Lung Infection With Pseudomonas Aeruginosa in Cystic Fibrosis Novartis Pharmaceuticals 17
Testing effectiveness (Phase 2)Study completedNCT03638830What this trial is testingSafety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. AeruginosaWho this might be right forPatients With Complicated Urinary Tract Infections Caused by P. AeruginosaPseudomonas AeruginosaPseudomonas Infections+1 more Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 777
Post-approval studies (Phase 4)Ended earlyNCT00333385What this trial is testingContinuous Versus Short Infusions of Ceftazidime in Cystic FibrosisWho this might be right forCystic FibrosisPseudomonas AeruginosaPulmonary Exacerbation Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche 120
Testing effectiveness (Phase 2)Study completedNCT00777296What this trial is testingMultidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™)Who this might be right forCystic Fibrosis Insmed Incorporated 66
Testing effectiveness (Phase 2)Study completedNCT06016088What this trial is testingA Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung InfectionWho this might be right forCystic Fibrosis LungRespiratory Infections, Recurrent, ChronicPseudomonas Aeruginosa Respirion Pharmaceuticals Pty Ltd 71
Testing effectiveness (Phase 2)Study completedNCT03218917What this trial is testingAssessment of INS1007 in Participants With Non-Cystic Fibrosis BronchiectasisWho this might be right forNon-Cystic Fibrosis Bronchiectasis Insmed Incorporated 256
Large-scale testing (Phase 3)Study completedNCT01316276What this trial is testingExtension Study of Liposomal Amikacin for Inhalation in Cystic Fibrosis (CF) Patients With Chronic Pseudomonas Aeruginosa (Pa) InfectionWho this might be right forCystic Fibrosis Insmed Incorporated 206
Testing effectiveness (Phase 2)Study completedNCT00598325What this trial is testingAntibody and Safety Study of 6 Doses of NicVAX in SmokersWho this might be right forSmoking Nabi Biopharmaceuticals 74
Testing effectiveness (Phase 2)Study completedNCT00004747What this trial is testingPhase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic FibrosisWho this might be right forCystic FibrosisBacterial Infections National Center for Research Resources (NCRR) 170
Testing effectiveness (Phase 2)Looking for participantsNCT07774403What this trial is testingAZD0292 in Chinese Participants With Bronchiectasis and Chronic Pseudomonas Aeruginosa ColonizationWho this might be right forBronchiectasis With Pseudomonas Aeruginosa Colonization AstraZeneca 84
Early research (Phase 1)Study completedNCT01116089What this trial is testingPharmacokinetic Study of Bramitob® Administered for Inhalation by PARI eFlow® vs PARI LC® PLUS NebulizerWho this might be right forCystic Fibrosis Chiesi Farmaceutici S.p.A. 25
Not applicableApproved For MarketingNCT00499720What this trial is testingAztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway InfectionWho this might be right forCystic FibrosisPseudomonas Aeruginosa Airway Infection Gilead Sciences